Epstein–Barr virus-associated diseases are important global health concerns. As a group I
carcinogen, EBV accounts for 1.5% of human malignances, including both epithelial-and …

Simple Summary Nasopharyngeal carcinoma is a serious major public health problem in its
endemic countries. Up to 80% of NPC patients with locally advanced disease or distant …

Despite significant medical advancement, nasopharyngeal carcinoma (NPC) remains one of
the most difficult types of cancer to detect and treat. Circular RNA (circRNA) signatures may …

Radiation therapy is the mainstay of salvage therapy for nasopharyngeal carcinoma (NPC).
However, radiation therapy efficacy is limited by radioresistance that can cause local …

Nasopharyngeal carcinoma (NPC) is the malignant tumor with ethnic and geographical
distribution preference. Although intensity-modulated radiotherapy (IMRT)-based …

Background Aberrant methylation of DNA plays an important role in the pathogenesis of
nasopharyngeal carcinoma (NPC). In the current study, we aimed to integrate three cohorts …

Protein regulator of cytokinesis 1 (PRC1) has been reported in correlation with various
malignancies. Functionality of PRC1 in nasopharyngeal carcinoma (NPC) was investigated …

Radiotherapy is a conventional and effective treatment method for nasopharyngeal
carcinoma (NPC), although it can fail, mainly because radioresistance results in residual or …

Nasopharyngeal carcinoma (NPC) is an aggressive malignancy with high propensity for
lymphatic spread and distant metastasis. It is prominent as an endemic malignancy in …

Ionizing radiation (IR) is a conventional cancer therapeutic, to which cancer cells develop
radioresistance with exposure. The residual cancer cells after radiation treatment also have …